Synergistic increase in osteosarcoma cell sensitivity to photodynamic therapy with aminolevulinic acid hexyl ester in the presence of hyperthermia

Photomedicine and Laser Surgery

Volumn 27, Issue 5, 2009, Pages 791-797

  Yanase, Shigeaki ^a,b   Nomura, Jouji ^a   Matsumura, Yoshihiko ^a   Watanabe, Yoshihiro ^a   Tagawa, Toshiro ^a  

^a MIE UNIVERSITY   (Japan)

^b National Hospital Organization   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; CELL LINES; COMBINATION THERAPY; INTRACELLULAR ACCUMULATION; METABOLIC PRODUCTS; NEAR INFRARED; OSTEOSARCOMA CELLS; PHOTO-TOXICITY; PROTOPORPHYRIN IX; SURVIVAL RATE;

ACIDS; CELL CULTURE; ESTERIFICATION; ESTERS; FLOW CYTOMETRY; HYPERTHERMIA THERAPY; IRRADIATION; OPTICAL MATERIALS; PHOTODYNAMIC THERAPY; PLASMONS; SLIDING MODE CONTROL; TUMORS;

CELLS;

AMINOLEVULINIC ACID HEXYL ESTER; PROTOPORPHYRIN;

ADULT; ARTICLE; BIOACCUMULATION; CASE REPORT; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; INDUCED HYPOTHERMIA; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; OSTEOSARCOMA CELL; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; RADIATION DOSE; SURVIVAL RATE; TEMPERATURE;

AMINOLEVULINIC ACID; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; INFRARED RAYS; MANDIBULAR NEOPLASMS; OSTEOSARCOMA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS;

EID: 70449086467     PISSN: 15495418     EISSN: None     Source Type: Journal    
DOI: 10.1089/pho.2008.2329     Document Type: Article

References (29)

1. Morgan, J., and Oseroff, A.R. (2001). Mitochondria-based photodynamic anti-cancer therapy. Adv. Drug Deliv. 49, 71-86.
2. Dougherty, T.J. (2002). An update on photodynamic therapy applications. J. Clin. Laser Med. Surg. 20, 3-7.
3. Schweitzer, V.G. (1990). Photodynamic therapy for treatment of head and neck cancer. Otolaryngol. Head Neck Surg. 102, 225-232.
4. Manivasager, V., Heng, P.W., Hao, J., Zheng, W., Soo, K.C., and Olivo, M. (2003). A study of 5-aminolevulinic acid and its methyl ester used in in vitro and in vivo systems of human bladder cancer. Int. J. Oncol. 22, 313-318.
5. Peng, Q., Warloe, T., Berg, K., et al. (1997). 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges. Cancer 79, 2282-2308. (Pubitemid 27251011)
6. Xu, S., Wang, X., Xu, W., Xia, Y., and Zhang, C. (2002). Evaluation of photodynamic therapy of skin cancers with partial differential alpha-aminolevulinic acid. Chin. Med. J. (Engl.) 115, 1141-1145.
7. de Blois, A.W., Thissen, M.R., de Bruijn, H.S., et al. (2001). In vivo pharmacokinetics of protoporphyrin IX accumulation following intracutaneous injection of 5-aminolevulinic acid. J. Photochem. Photobiol. B. 61, 21-29.
8. Harmon, B.V., Corder, A.M., Collins, R.J., et al. (1990). Cell death induced in a murine mastocytoma by 42-47 degrees C heating in vitro: evidence that the form of death changes from apoptosis to necrosis above a critical heat load. Int. J. Radiat. Biol. 58, 845-858.
9. Remani, P., Ostapenko, V.V., Akagi, K., Bhattathiri, V.N., Nair, M.K., and Tanaka, Y. (1999). Relation of transmembrane potential to cell survival following hyperthermia in HeLa cells. Cancer Lett. 144, 117-123.
10. Yuen, W.F., Fung, K.P., Lee, C.Y., et al. (2000). Hyperthermia and tumour necrosis factor-alpha induced apoptosis via mitochondrial damage. Life Sci. 67, 725-732.
11. Dewey, W.C., Hopwood, L.E., Sapareto, S.A., and Gerweck, L.E. (1977). Cellular responses to combinations of hyperthermia and radiation. Radiology 123, 463-474.
12. Yanase, S., Nomura, J., Matsumura, Y., et al. (2006). Synergistic interaction of 5-aminolevulinic acid-based photodynamic therapy with simultaneous hyperthermia in an osteosarcoma tumor model. Int. J. Oncol. 27, 365-373.
13. Rodriguez, L., Batlle, A., Venosa, G., et al. (2006). Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells. Br. J. Pharmacol. 147, 825-833.
14. Yanase, S., Nomura, J., Matsumura, Y., et al. (2005). Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia. Int. J. Oncol. 27, 193-201.
15. Tagawa, T., Nomura, J., Kihira, H., and Murata, M. (1989). A newly established osteosarcoma cell line from mandible. Mie Med. J. 39, 279-286.
16. Narita, M., Nomura, J., Nakase, M., et al. (2004). Characterization of the human mandibular osteoblastic osteosarcoma cell line HOSM-2 after long-term culture. Oral Oncol. 40, 742-750.
17. Seidl, J., Rauch, J., Krieg, R.C., Appel, S., Baumgartner, R., and Knuechel, R. (2001). Optimization of differential photodynamic effectiveness between normal and tumor urothelial cells using 5-aminolevulinic acid-induced protoporphyrin IX as sensitizer. Int. J. Cancer 92, 671-677.
18. Valeriote, F., and Lin, H. (1975). Synergistic interaction of anticancer agents: a cellular perspective. Cancer Chemother. Rep. 59, 895-900.
19. Nomura, J., Yanase, S., Tokuda, T., et al. (2006). Griseofulvin enhances the effect of aminolevulinic acid-based photodynamic therapy in vitro. Photomed. Laser Surg. 24, 186-191.
20. Tsai, T., Hong, R.L., Tsai, J.C., Lou, P.J., Ling, I.F., and Chen, C.T. (2004). Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7=ADR cells. Lasers Surg. Med. 34, 62-72.
21. Ji, Z., Yang, G., Vasovic, V., et al. (2006). Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines. J. Photochem. Photobiol. B. 84, 213-220.
22. Peng, Q., Moan, J., and Nesland, J.M. (1996). Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct. Pathol. 20, 109-129.
23. Luksiene, Z., Eggen, I., Moan, J., Nesland, J.M., and Peng, Q. (2001). Evaluation of protoporphyrin IX production, phototoxicity and cell death pathway induced by hexylester of 5- aminolevulinic acid in Reh and HPB-ALL cells. Cancer Lett. 169, 33-39.
24. Grebenova, D., Kuzelova, K., Smetana, K., et al. (2003). Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by 5-aminolevulinic acidbased photodynamic therapy in HL60 leukemia cells. J. Photochem. Photobiol. B. 69, 71-85.
25. Yow, C.M., Wong, C.K., Huang, Z., and Ho, R.J. (2007). Study of the efficacy and mechanism of ALA-mediated photodynamic therapy on human hepatocellular carcinoma cell. Liver Int. 27, 201-208.
26. Kuzelová , K., Grebenová , D., Pluskalová , M., Marinov, I., and Hrkal, Z. (2004). Early apoptotic features of K562 cell death induced by 5-aminolaevulinic acid-based photodynamic therapy. J. Photochem. Photobiol. B. 73, 67-78.
27. Samali, A., Cai, J., Zhivotovsky, B., Jones, D.P., and Orrenius, S. (1999). Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells. EMBO J. 18, 2040-2048.
28. Rasch, M.H., Tijssen, K. VanSteveninck, J., and Dubbelman, T.M. (1996). Synergistic interaction of photodynamic treatment with the sensitizer aluminum phthalocyanine and hyperthermia on loss of clonogenicity of CHO cells. Photochem. Photobiol. 64, 586-593.
29. Chen, B., Xu, Y., Agostinis, P., and De Witte, P.A. (2001). Synergistic effect of photodynamic therapy with hypericin in combination with hyperthermia on loss of clonogenicity of RIF-1 cells. Int. J. Oncol. 18, 1279-1285.